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Abstract 26 
Acute puerperal metritis (APM) and clinical metritis (CM) are uterine diseases frequently diagnosed 27 
in dairy cows. These diseases are responsible of important economic loss due to its effect not only 28 
on reproductive performance but also on milk production. The objective of this study was to assess 29 
the impact of two different treatments for metritis on dairy cows by measuring their reproductive 30 
performance in the next gestation. The endpoints to measure the reproductive performance 31 
included: the conception rate at first artificial insemination (AI), the number of days at conception 32 
and the proportion of non-pregnant cows at over 150 days after beginning milk production (>150  33 
DIM). The study was carried out in a high production dairy cow farm located in Lleida (North East 34 
Spain). Recordings of 1044 parturitions of 747 Holstein cows were controlled in this farm from 35 
2009 to 2014. Cows were diagnosed as suffering from metritis (APM or CM) if the following 36 
parameters were observed: an abnormally enlarged uterus, a fetid watery red-brown uterine 37 
discharge with (APM) or without (CM) fever (>39.5 ºC) and presence (APM) or absence (CM) of 38 
signs of systemic illness (decreased milk production, dullness or other signs of toxemia) within 21 39 
days postpartum. Afterwards, cows suffering from metritis (APM or CM) were randomly assigned 40 
and balanced to two groups: 1) Animals receiving parenteral amoxicillin intramuscularly plus 41 
intrauterine infusion with oxytetracycline (P+I group); and 2) Animals receiving only parenteral 42 
amoxicillin intramuscularly (P group). Furthermore, reproductive performance of cows without 43 
metritis were used as reference (control group).  44 
Metritis was diagnosed in 27.5 % of the total parturitions included in the study (288 out of 1044). In 45 
particular, metritis was diagnosed in 30.5% (118 out of 387) and 25.9% (170 out of 657) of 46 
parturitions from heifers and multiparous cows, respectively. Reproductive performance was not 47 
significantly affected  by the parity, the season at first AI, the season at conception, the bull or the 48 
inseminator. The P+I treatment was able to significantly reduce the number of days at first 49 
insemination and at conception when compared to the P treatment in heifers. In multiparous cows, 50 
this significant effect was only observed for days at conception. Additionally, the P+I treatment was 51 
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able to significantly increase the percentage of pregnant animals at first insemination and decrease 52 
the percentage of non-pregnant cows at >150 DIM for both heifers and multiparous cows when 53 
compared to the P treatment. 54 
 55 
Key words: Metritis, treatment strategies, reproductive performance, dairy cattle. 56 
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1.- Introduction 75 
The reproductive performance of a cow after parturition is affected by many factors such as parity, 76 
the number of days without milk production, body weight loss, heat stress, season at first artificial 77 
insemination (AI), season at conception, bull used for the AI and the technician that carries out the 78 
AI [1]. Moreover, clinical conditions such as clinical ketosis, clinical hypocalcemia, and uterine 79 
diseases could negatively affect the future reproductive performance of the cow [2,3]. 80 
Metritis can cause important economic losses during the postpartum period due to poor 81 
reproductive performance, lower milk production and an increase in the culling rate in comparison 82 
with non-affected cows. The animals affected by metritis are unable to control the growth of aerobic 83 
and anaerobic bacteria in uterine lumen due to an abnormal post-partum uterine involution that may 84 
be triggered by immune, nutritional and management factors [4]. Metritis is characterized by an 85 
inflammation of the uterine tract with local and/or systemic implications for the cow [5]. Therefore, 86 
diagnosis and treatment of postpartum uterine diseases is common in dairy practice.   87 
It is very important to clearly define the diagnostic criteria for metritis in cows. Thus, two types of 88 
metritis are usually observed under field conditions in the early postpartum period (1-21 days after 89 
parturition). On one hand, acute puerperal metritis (APM) is diagnosed in cows that have an 90 
abnormally enlarged uterus and a fetid, watery, reddish-brown uterine discharge, which is also 91 
associated with clinical signs of systemic disease (decreased milk yield, dullness or other signs of 92 
toxemia) and fever (>39.5ºC) within 21 days postpartum. On the other hand, clinical metritis (CM) 93 
is described in cows that have an abnormally enlarged uterus and a purulent uterine discharge 94 
detectable in the vagina within 21 days after parturition in the absence of clinical signs of systemic 95 
disease [6, 7, 8 ]. In any case, diagnosis of metritis is challenging for researchers and practitioners 96 
under field conditions [6, 7, 9 ] and the distinction between APM and CM is frequently not 97 
straightforward. Fortunately, the basis of the treatment is common for both types of metritis [10]. 98 
 It has been described in the literature that the treatment for cows suffering from metritis during the 99 
early post partum period is important to minimize this risk of low milk production, increase 100 
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reproduction performance in the next gestation and reduce culling risk [7]. There are many 101 
treatment protocols for cows with metritis. These treatments include various combinations of 102 
antimicrobials, administered by intrauterine and/or parenteral routes, and/or hormones [7, 8]. Thus, 103 
beta-lactamic antibiotics (mainly amoxicillin and cephalosporins) are efficacious to treat and 104 
prevent metritis after their parenteral administration under field conditions [10, 11]. Tetracyclines 105 
administered by intrauterine route are extensively used in uterine disease, although their efficacy 106 
has been questioned in the literature [12, 13, 14]. 107 
 108 
The objective of this study was to assess the impact of two different treatments for metritis during 109 
early postpartum period (1-21 days) in dairy cows by measuring their reproductive performance in 110 
the next gestation. The endpoints to measure the reproductive performance included: the conception 111 
rate at first AI, the number of days at conception and the proportion of non-pregnant cows at >150 112 
days in milk production (DIM).  113 
 114 
2.- Materials and Methods 115 
2.1- Animals and herd. 116 
During a five-year period (January 2009- January 2014), a total of 1222 cow parturitions were 117 
evaluated for routine post-partum examination; of these, 414 corresponded to heifers and 808 to 118 
multiparous cows. Parturitions complicated by other diseases that could also affect the reproductive 119 
performance (clinical ketosis, left displaced abomasum (LDA), clinical mastitis, lameness, 120 
pneumonia, ovarian disorders such as ovarian cysts and other uterine disease such as endometritis 121 
and pyometra) were excluded from the study. Culled or dead cows from either group without full 122 
reproductive history were also excluded. Eventually, 1044 parturitions were finally included in the 123 
study, 387 corresponding to heifers and 657 to multiparous cows. The exact numbers of excluded 124 
cows for the various reasons exposed, as well as group allocation for enrolled cows are detailed in 125 
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Figure 1.   126 
The study was conducted on a single high production commercial dairy farm in Lleida (North East 127 
Spain) over a period of five years (2009-2014). During the study period, this farm was housing an 128 
average of 330 lactating Holstein cows with an average production of 11,100 kg of milk (3.6% Fat 129 
and 3.3% Protein) in 305 days by cow. Cows were housed in five straw-bedded free- stall barns and 130 
they were fed a total mixed ration consisting of corn silage, grass silage, and concentrates. Cows 131 
were milked three times a day (at 4 AM, 12 PM, and 8 PM). Each cow was sampled and analyzed 132 
for milk quality (fat, protein, and lactose concentration) and somatic cell count by the Central 133 
Laboratory for Milk Recording (ALLIC, Catalonia) once a month. 134 
Breeding management was carried out by AI with Holstein semen and performed by a highly 135 
trained technician or veterinarians specialized in cattle reproduction. Cows were bred on observed 136 
estrus or diagnosed by a computerized pedometry system (Afimilk, Kibbutz Afikim, 1514800, 137 
Israel). Breeding programs based on the use of hormones were not applied and it was decided not to 138 
inseminate heifers and multiparious cows before 90 and 70 days post-partum, respectively. This 139 
decision was made considering historic data about reproductive performance in this particular farm.  140 
Transrectal ultrasonography (Easi Scan, 4.5 MHz - 8.5 MHz, BCF Technology, Ltd. Scotland) was 141 
used to perform pregnancy diagnosis at 32-40 days post AI as well as to detect uterine and/or 142 
ovarian disorders such as clinical endometritis, pyometra, ovarian cysts and ovarian cyclicity 143 
failure. This reproductive control was carried out every Tuesday and Friday and also included post -144 
partum examination (1-21 post-partum) and diagnosis and treatment of non-cycling or silent estrus 145 
cows. Non-cycling or silent estrus cows were treated with hormones. Various combinations of 146 
prostaglandins, gonadotropin-relising hormone GnRH and progesterone were used according to 147 
clinical criteria. In any case, these animals were excluded from the study to avoid any confounding 148 
factor in the data analysis. Finally, animals diagnosed and treated for other uterine and/or ovarian 149 
disorders outside the period of 1-21 days postpartum were excluded from the study to avoid any 150 
bias. 151 
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Clinical, reproduction, production and management data were recorded by the herd manager and the 152 
attending veterinarians using specific software (Afimilk, Kibbutz Afikim, 1514800, Israel). Lleida 153 
has a long “heat stress risk season” (from May to October,) that could affect the reproductive 154 
performance [15]. It is well known that heat stress can affect immunological status of the cows [16] 155 
and it could significantly affect the prevalence of uterine diseases and/or its severity. For the 156 
purposes of this study, the year was divided in four periods; 1 (1st January-31st March), 2 (1st 157 
April-30th June), 3 (1st July-30th September) and 4 (1st October-31st December).  158 
Other factors that have been described as affecting the reproductive performance of cows are the 159 
origin of semen (bull factor) and the technicians that perform the AI. Both factors were excluded 160 
from the data analysis because the same number of cows were inseminated in each experimental 161 
group regarding the origin of semen and the technician. 162 
 163 
2.2.- Definition of metritis case 164 
All the cows underwent a clinical examination every 24 hours during the first 21 days post-partum. 165 
For each animal, the ruminal motility, breathing rate, consistency of the faeces, rectal temperature, 166 
milk production, pedometry readings, body weight (BW) and milk conductivity were recorded. 167 
Additionally, rectal palpation and observation of vaginal discharge were carried out every Tuesday 168 
and Friday from day 1 to day 21 postpartum, (Table 1).  169 
Vaginal discharge (VD) was collected through rectal palpation massage to minimize not only 170 
contamination of the vagina and uterus but also microtrauma in the area. Quantity, color, proportion 171 
of pus, consistency and smell were evaluated [6]. All examinations were performed by the same 172 
veterinarian in order to minimize bias in the clinical record [17]. Cows that did not expel their fetal 173 
membranes (44 out of 1222) within 24 hours postpartum were diagnosed with retained fetal 174 
membranes (RFM). These animals were treated with one injection of 37.5 mg of sodium selenium 175 
and 1250 mg of α-Tocoferol acetate (Hipravit Selenio, HIPRA, Spain) and oral calcium (Bovicalk, 176 
Boehringer Ingelheim, Germany) every 12 hours until fetal membranes were expelled.  In these 177 
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cows, rectal palpation was performed every 24h. If fever (>39,5ºC) was present, animals were 178 
treated with flunixin meglumine (Finadyne®, MSD Animal Health) at a dose of 2.2 mg/Kg BW/ 24 179 
h for three days. Once fetal membranes were expelled (average of 48h postpartum), animals were 180 
classified according to Table 1. No attempt was made to manually remove the retained fetal 181 
membranes.  182 
  183 
In this study, metritis (APM and CM) was diagnosed in animals that had an abnormally enlarged 184 
uterus and a purulent or a fetid red-brown watery uterine discharge detectable in the vagina within 185 
21 days after parturition. The presence or absence of pyrexia (>39.5ºC) and other signs of systemic 186 
illness such as reduced milk yield, dullness, inappetence or anorexia, elevated heart rate, and 187 
apparent dehydration determined if animals were included in the APM group (present) or  the CM 188 
group (absent) [6]. Cows treated with anti-inflammatory drugs, antimicrobial drugs or hormones for 189 
diseases not related with the study (e.g., acute mastitis, lameness, LDA, ketosis, other uterine or 190 
ovary disorders) were excluded from the trial.  191 
 192 
2.3.- Experimental design 193 
Cows were included in the study at day 1 after calving. Reproductive performance of healthy cows 194 
was used as reference (control group). Cows suffering from metritis were randomly allocated to one 195 
of two groups according to the last digit of their ear tag. Thus, cows with an odd number (1, 3, 5, 7,  196 
9) were allocated to P group. In this group, cows only received parenteral amoxicillin by 197 
intramuscular route. Cows with an even number in their ear tag (0, 2, 4, 6, 8) were allocated to 198 
group P+I. In this group, cows received parenteral amoxicillin by intramuscular route plus an 199 
intrauterine infusion with oxytetracycline. Briefly, cows included in group P received a systemic 200 
antimicrobial treatment of amoxycillin trihidrate (Amoxoil Retard®, Laboratiorios SYVA SA) at 15 201 
mg/kg BW every 48h by intramuscular route for three times. Injection was applied on the neck and 202 
the injection volume was always less than 20 mL on the same inoculation point. Cows included in 203 
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the P+I group received the same systemic treatment as group P plus 8000 mg of oxytetracycline 204 
dihidrate (Tenalina L.A.®, CEVA Santé Animal) (200 mg/ml) via intrauterine infusion every 72-96 205 
hours twice.  Intrauterine infusion was applied with a disposable uterine catheter (53.5 cm Bovivet, 206 
Kruuse, Denmark) and a single use 50 cm
3
syringe. Cows that were diagnosed with metritis were 207 
considered cured when its classification was M0 or M1 (Table 1) after two regular rechecks. Cows 208 
allocated in any of the groups that showed fever were also treated with flunixin meglumine 209 
(Finadyne®, MSD Animal Health) at a dose of 2.2 mg/Kg BW/24 h for 3 days. 210 
 211 
2.4.- Monitoring of antimicrobial susceptibility throughout the trial 212 
Antimicrobial susceptibility (AS) for Escherichia coli (EC) and Trueperella pyogenes (TP) against 213 
amoxicillin and oxytetracycline was monitored every third month in this farm in, at least, four 214 
clinical cases. Briefly, AS tests were performed using the agar dilution method according to the 215 
Clinical Laboratory Standard Institute (CLSI) guideline M31-A3 in a commercial diagnostic 216 
laboratory. The threshold values to distinguish between susceptible and resistant microorganisms 217 
are detailed in Table 2. 218 
 219 
2.5.- Statistical Analysis. 220 
All statistical analyses were carried out using the SAS system V.9.1.3 (SAS institute Inc, Cary, NC, 221 
USA). For all analyses, the individual cow was used as the experimental unit and the data was 222 
grouped taking into account the parity of the cows: Heifers (first parturition) versus multiparous 223 
cows (two to six parturitions). The significance level (p) was set at 0.05 with statistical tendencies 224 
reported when P<0.10. The variables included in the statistical analyses were classified as nominal 225 
(pregnancy and delivery season), ordinal (parity) or continuous (days to conception and DIM). 226 
Shapiro Wilk´s and Levene tests were used to evaluate the normality of the distribution of the 227 
continuous variables and the homogeneity of variances, respectively. Statistical analyses were 228 
performed to test the association between the different experimental groups (control, P or P+I) with 229 
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the conception rate at first AI, days to conception and the proportion of non-pregnant cows with a 230 
DIM higher than 150 days. Contingency tables (Chi-square or Fischer exact tests) were used when 231 
the association between nominal and ordinal variables was assessed. To study the association 232 
between nominal or ordinal variables with the continuous non-normally distributed variables, the 233 
Wilcoxon test (with the U Mann-Whitney test to compare each pair of values) was used. To analyse 234 
the association between continuous normally distributed variables and nominal or ordinal variables, 235 
an ANOVA test (with Student’s T-test to compare each pair of values) was used. 236 
 237 
3.- Results. 238 
3.1.- Description of metritis in the population 239 
Metritis was diagnosed in 288 out of 1044 parturitions finally included in the study, (27.5% 240 
prevalence). In particular, metritis was diagnosed in 30.5% (118 out of 387) and 25.9% (170 out of 241 
657) of parturitions resulting from heifers and multiparous cows, respectively. Cows scored as M2 242 
(Table 1) were diagnosed with APM in 83 out of 288 cases of metritis (28.8% prevalence). These 243 
animals had an abnormally enlarged uterus, a purulent or a fetid red-brown watery uterine discharge 244 
detectable in the vagina, pyrexia (>39.5ºC) and/or systemic illness such as reduced milk yield, 245 
dullness, inappetence or anorexia, elevated heart rate, and apparent dehydration. Two-hundred and 246 
five out of 288 cows with uterine disease (71.2% prevalence) were diagnosed with CM (cows 247 
graded as M2 but without pyrexia (<39.5ºC) and/or systemic illness). Taking parity into account, 248 
32.2% of heifers affected with metritis, suffered from APM (38 out of 118) and 67.8% from CM (80 249 
out of 118). Within multiparous cows, 30.6% (52 out of 170) and 69.4% (118 out of 170) were 250 
diagnosed as APM and CM, respectively. Significant differences in the prevalence of each type of 251 
metritis between heifers and multiparous cows or within groups of treatment were not observed  at 252 
the beginning of the trial (basal homogeneity). Thus, 27.9% (43 out of 154) and 72.2% (111 out of 253 
154) of the animals were diagnosed as APM and CM, respectively in Group P and the prevalence of 254 
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APM was 29.8% (40 out of 134) and 70.2% of CM (94 out of 134), respectively for group P+I at 255 
the beginning of the trial. 256 
 257 
3.2.- Reproductive performance in the population 258 
Reproductive performance was not significantly affected  by the number of parity, the season at first 259 
AI, the season at conception, the bull or the inseminator that carried out the AI, neither in healthy 260 
nor in metritis affected cows. Considering all the animals included in the study (healthy and metritis 261 
affected cows), the number of days at first insemination was not significantly different between 262 
heifers and multiparous cows but the number of days at conception was significantly higher in 263 
multiparous cows (129.5+60.3) than in heifers (118.6+53). In heifers, the conception rate at first 264 
insemination was significantly higher than in multiparous cows, whereas the percentage of non-265 
pregnant animals at >150 DIM was significantly lower than in multiparous cows. For this reason, 266 
the analysis of the treatment efficacy was carried out separately for heifers and multiparous cows.  267 
 268 
3.3.- Bacteriological examination 269 
The isolates of EC and TP obtained were susceptible against amoxicillin and/or oxytetracycline 270 
throughout the trial, considering the threshold values detailed in Table 2.  271 
 272 
3.4.- Effect of the two antibiotic treatments on the reproductive performance 273 
In heifers with metritis, The P+I treatment was able to significantly reduce the number of days at 274 
first insemination (80.5±11.6 vs 91.9±24.2) and at conception (116.8±50.5 vs 151.5±67.7) in 275 
comparison with the P treatment. In the case of multiparous cows, this significant effect was only 276 
observed in the case of days at conception (140.8±62.7 vs 166.8±67.5) (Figure 2). In heifers, when 277 
the P+I group was compared to the control group, no significant differences were observed for any 278 
of these two parameters. However, in the case of multiparous cows, the number of days at 279 
conception for both P and P+I groups was significantly higher than in the control group 280 
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(120.6±55.5) (Figure 2). The P+I treatment was able to significantly increase the percentage of 281 
pregnant cows at first insemination for both heifers (47.5%) and multiparous cows (30.5%) in 282 
comparison with the P treatment (28.2% for heifers and 15.3% for multiparous) (Figure 3). The P+I 283 
treatment was able to significantly decrease the percentage of non-pregnant cows at >150 DIM 284 
when compared to the P treatment (18.3 % vs 42.4% for heifers and 38% vs 57.1% for multiparous 285 
cows, respectively). Finally, in heifers, no significant differences in the percentage of pregnant 286 
animals at first insemination or in the percentage of non-pregnant cows at >150 DIM were observed 287 
between the control group and the P+I group. However, in multiparous cows, both parameters for 288 
the P and P+I groups had significantly higher values than those observed in the control group 289 
(Figure 3). 290 
 291 
4.- Discussion. 292 
The main goal of this study was to assess the impact of two different treatments, parenteral only vs 293 
parenteral plus intrauterine infusion, for dairy cows affected with metritis by measuring their 294 
reproductive performance in the next gestation: days at first AI, conception rate at first AI and 295 
percentage of non pregnant animals at 150 DIM. These results were compared with the values 296 
observed for healthy cows as a reference. The authors did not consider the possibility to include a 297 
negative control group (affected with metritis  and not treated with antimicrobials) due to welfare 298 
reasons and the increased risk of death or culling for these non-treated sick animals. Metritis 299 
decreases the reproductive performance of dairy cattle [3]. In this study, the control group (healthy 300 
cows) always showed better reproductive performance than metritis-affected cows. The results 301 
suggest that the combination of amoxicillin, administered by parenteral route, plus intrauterine 302 
infusion of oxytetracycline is more efficacious than the administration of parenteral amoxycillin 303 
alone for the treatment of metritis, when taking into account the reproductive performance in the 304 
next gestation as an end-point. This statement was true for both heifers and multiparous cows, 305 
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although the positive results were more consistently observed in heifers than in multiparous cows 306 
for all the parameters evaluated. 307 
In the literature, various techniques to diagnose metritis in cows can be found [6, 9]. In this study, 308 
metritis (APM and CM) was described as an abnormally enlarged uterus and a fetid watery red-309 
brown or purulent uterine discharge showing or not pyrexia (>39.5ºC), with or without signs of 310 
systemic illness within 21 days after parturition [6]. The authors decided to include both pyretic and 311 
non pyretic animals since this is the way it has been previously described by other authors [4, 10]. 312 
The authors used a method with high sensitivity to diagnose metritis in cows, which avoids the risk 313 
of underestimating metritis if only milk production or rectal temperature are considered as 314 
diagnostic, but at the same time, trying to make it a reasonably fast, sensitive and economic 315 
procedure for the farmer. The procedure takes some time to implement but once established as a 316 
routine in the farm, the authors believe that it can be very useful to diagnose post-partum disease 317 
and treat the animals during an early stage of illness, which improves the productive and 318 
reproductive performance of the cows. It means that the animals included in this study were 319 
diagnosed in a very early stage of the disease. This fact must be taken into account when the 320 
treatment efficacy is compared with the results obtained by other authors. 321 
 322 
In this study, the overall prevalence of metritis is close to 28%. This prevalence can vary 323 
considerably between heifers and cows, between different farms and between studies. Thus, values 324 
between 2.2% and 42.3% have been observed in previous studies [14, 18, 19]. For this reason, the 325 
farm included in this trial could be considered representative of a high production dairy cattle 326 
operation with a prevalence of metritis within reported values. Thus, the reproductive performance 327 
of healty or metritis-affected cows was not affected by factors directly or indirectly associated with 328 
management (season at first AI, season at conception, the bull and the inseminator that carried out 329 
the AI). Taken together, these results suggest that the farm where the study was carried out was 330 
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appropriate to assess the impact of two different treatments for metritis in dairy cows by measuring 331 
their reproductive performance in the next pregnancy. 332 
 333 
The bacteria most commonly isolated from metritis-affected dairy cows are well described in 334 
several studies; these include EC and TP [20, 21, 22]. Fusobacterium necrophorum and 335 
Bacterioides spp are also recognized as opportunistic bacteria that can cause metritis [23, 24]. In 336 
particular, it has been long suggested that uterine infections might depend on pathogenic synergism 337 
between EC, TP and bacteria from other groups.  However, recent studies have suggested that the 338 
diversity of the uterine bacterial composition in dairy cows is likely to be even more complex than 339 
previously described by traditional culture-dependent methods [25]. Additionally, it is necessary to 340 
know the AS of the bacteria involved in clinical cases of bovine metritis in order to choose the most 341 
suitable antimicrobial. However, it is only feasible to determine this antimicrobial susceptibility in 342 
the isolated bacteria. In our case, the isolates of EC and TP obtained were susceptible against 343 
amoxicillin and/or oxytetracycline throughout the trial. Thus, the use of both antimicrobials in this 344 
farm did not seem to generate antimicrobial resistance for these bacteria during five years. 345 
Nevertheless, the diversity of the bacterial species involved in clinical cases of metritis makes 346 
absolutely compulsory to carry out clinical trials that measure clinical efficacy instead of carrying 347 
out only pharmacokinetic/pharmacodynamic studies that only take into account pharmacodynamic 348 
data from only the most commonly isolated bacteria (EC and TP) [26]. 349 
 350 
The use of antimicrobials is widely accepted to cope with infections in the genital tract, mainly in 351 
the case of metritis [27]. The rationale behind this therapeutic approach is to reduce the number of 352 
pathogens in the uterine cavity and consequently mitigate the associated inflammation, enhance the 353 
local immune defense, and facilitate the repair of the endometrium for a faster return to a normal 354 
uterine status. Unfortunately, there are few available data about the penetration of parenterally-355 
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administered antibiotics into the cow genital tract. In humans, an endometrium to plasma 356 
concentration ratio of 0.6 and 0.4 for quinolones and a beta-lactamics, respectively, has been 357 
established [28, 29]. It is possible that a similar ratio could be achieved in cows. Intrauterine 358 
administration of antibiotics is expected to reach a higher antibiotic concentration in the 359 
endometrium compared to systemic administration and it is a common route to administer 360 
antimicrobials for metritis in cows and mares [30]. Thus, considering the administered dose of 361 
oxytetracycline (8000 mg) and the uterine volume post-partum (2000 mL) [31], an extraordinarily 362 
high oxytetracycline concentration in uterine lumen (4 mg/mL) was expected to be achieved. This 363 
concentration is notably higher than the established Minimum inhibitory Concentration for the 90% 364 
of the strains (MIC9) for AP and EC in case of bovine metritis [32, 33, 34]. 365 
 366 
To the best of the authors’ knowledge, no previous studies have explored the same combination of 367 
antimicrobials to treat cows diagnosed with early postpartum metritis.  However, it has been 368 
described in the literature that the administration of beta-lactamics by parenteral route is able to 369 
improve the reproductive performance of metritis-affected cows [35]. The use of ceftiofur, 370 
administered intramuscularly, with or without a combination of cloxacillin plus ampicillin by 371 
intrauterine infusion, did not show differences in reproductive performance between groups in cows 372 
diagnosed with toxic puerperal metritis (TPM) [36]. In conclusion, there is a lot of variation in the 373 
treatment outcome of uterine disease using beta-lactamic antibiotics [13, 37, 38, 39, 40]. Similar 374 
studies have described a significant improvement in reproduction parameters applying an 375 
intrauterine infusion of tetracyclines in cows and heifers with CM [14] but other studies did not find 376 
significant differences in the treatment outcome between various combinations of intrauterine 377 
infusion of tetracyclines for the treatment of metritis [39], endometritis [12, 13] or retained fetal 378 
membranes [14, 42]. In our study, the combination of amoxicillin, by parenteral route, plus 379 
intrauterine infusion of oxytetracycline is more efficacious than using only the parenteral route. It 380 
must be highlighted that, in the current study, the dose of oxytetracyclines was higher and the 381 
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duration of administration was longer than the dosage regimen used in other studies [14, 39]. 382 
Globally, these results suggest that local treatment with antibiotics can be important to heal the 383 
genital tract and prepare it for the following pregnancy. The efficacy of intrauterine tetracycline 384 
might be related to other uncultured or unknown organisms that are sensitive to this antimicrobial 385 
and that are not easily isolated with standard microbiological techniques. Finally, this efficacy 386 
might also be related to non-antimicrobial effects of tetracyclines such as anti-inflammatory effects. 387 
In this regard, tetracyclines are potent inhibitors matrix metalloproteinases  and inducible Nitric 388 
Oxide Synthase, which are known to play a role in the mediation and control of mucosal 389 
inflammation and immune response [43, 44]. 390 
 391 
In conclusion, based on reproductive performance as an end-point parameter, treatment of metritis 392 
with parenteral amoxicillin plus oxytetracycline via intrauterine route was superior in comparison 393 
with only the parenteral administration of amoxicillin.  394 
 395 
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 511 
Table 1. Classification of cows according to the type of vaginal discharge during the post-partum 512 
period  513 
  514 
CODE TYPE OF VAGINAL 
DISCHARGE 
DIAGNOSIS TREATMENT 
M0 No vaginal discharge.  Healthy None 
M1 Normal lochial 
secretion, odorless, 
viscous and translucid.  
Healthy None 
M1S Normal lochial 
secretion, odorless, 
viscous and reddish 
brown.  
Healthy None 
M2 Purulent or fetid, 
watery  and reddish-
brown  
Metritis P: Parenteral Amoxycillin 
P+I: Parenteral 
Amoxicillin plus 
intrauterine infusion of 
Oxytetracycline. 
 515 
516 
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Table 2.- Minimal inhibitory concentration (MIC) breakpoints for Escherichia coli and Trueperella 517 
pyogenes isolated from bovine metritis cases 518 
 519 
   MIC 
breakpoint 
( g/mL) 
   
  Escherichia 
coli 
  Trueperella 
pyogenes 
 
 S I R S I R 
Antimicrobial 
agent 
      
Amoxicillin* <0.25 0.5 >1 <2 4 >8 
Oxytetracycline** <4 8 >16 <4 8 >16 
* According to the breakpoint established for similar pathogens in other veterinary species 520 
** Derived from human data 521 
S= Sensitive, I= Intermediate, R= Resistant 522 
 523 
 524 
 525 
 526 
 527 
 528 
 529 
 530 
 531 
 532 
Figure 1.- Allocation of parturitions from animals discarded and enrolled in the study . 
 
 
 
 
Figure
 
Figure 2.- Number of days at first artificial insemination (A) and at conception (B) in 
healthy cows (control) or in metritis affected animals treated with two different 
treaments (P or P+I). Groups connected with different letter or number means 
statistically significant differences between them (p<0.05). 
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Figure 3.- Conception rate at first insemination (A) and percentage of non-pregnant 
cows at >150 days DIM (B) in healthy cows (control) or in metritis affected animals 
treated with two different treaments (P or P+I). Groups connected with different letter or 
number means statistically significant differences between them (p<0.05). 
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Abstract 26 
Acute puerperal metritis (APM) and clinical metritis (CM) are uterine diseases frequently diagnosed 27 
in dairy cows. These diseases are responsible of important economic loss due to its effect not only 28 
on reproductive performance but also on milk production. The objective of this study was to assess 29 
the impact of two different treatments for metritis on dairy cows by measuring their reproductive 30 
performance in the next gestation. The endpoints to measure the reproductive performance 31 
included: the conception rate at first artificial insemination (AI), the number of days at conception 32 
and the proportion of non-pregnant cows at over 150 days after beginning milk production (>150  33 
DIM). The study was carried out in a high production dairy cow farm located in Lleida (North East 34 
Spain). Recordings of 1044 parturitions of 747 Holstein cows were controlled in this farm from 35 
2009 to 2014. Cows were diagnosed as suffering from metritis (APM or CM) if the following 36 
parameters were observed: an abnormally enlarged uterus, a fetid watery red-brown uterine 37 
discharge with (APM) or without (CM) fever (>39.5 ºC) and presence (APM) or absence (CM) of 38 
signs of systemic illness (decreased milk production, dullness or other signs of toxemia) within 21 39 
days postpartum. Afterwards, cows suffering from metritis (APM or CM) were randomly assigned 40 
and balanced to two groups: 1) Animals receiving parenteral amoxicillin intramuscularly plus 41 
intrauterine infusion with oxytetracycline (P+I group); and 2) Animals receiving only parenteral 42 
amoxicillin intramuscularly (P group). Furthermore, reproductive performance of cows without 43 
metritis were used as reference (control group).  44 
Metritis was diagnosed in 27.5 % of the total parturitions included in the study (288 out of 1044). In 45 
particular, metritis was diagnosed in 30.5% (118 out of 387) and 25.9% (170 out of 657) of 46 
parturitions from heifers and multiparous cows, respectively. Reproductive performance was not 47 
significantly affected  by the parity, the season at first AI, the season at conception, the bull or the 48 
inseminator. The P+I treatment was able to significantly reduce the number of days at first 49 
insemination and at conception when compared to the P treatment in heifers. In multiparous cows, 50 
this significant effect was only observed for days at conception. Additionally, the P+I treatment was 51 
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able to significantly increase the percentage of pregnant animals at first insemination and decrease 52 
the percentage of non-pregnant cows at >150 DIM for both heifers and multiparous cows when 53 
compared to the P treatment. 54 
 55 
Key words: Metritis, treatment strategies, reproductive performance, dairy cattle. 56 
 57 
 58 
 59 
 60 
 61 
 62 
 63 
 64 
 65 
 66 
 67 
 68 
 69 
 70 
 71 
 72 
 73 
 74 
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1.- Introduction 75 
The reproductive performance of a cow after parturition is affected by many factors such as parity, 76 
the number of days without milk production, body weight loss, heat stress, season at first artificial 77 
insemination (AI), season at conception, bull used for the AI and the technician that carries out the 78 
AI [1]. Moreover, clinical conditions such as clinical ketosis, clinical hypocalcemia, and uterine 79 
diseases could negatively affect the future reproductive performance of the cow [2,3]. 80 
Metritis can cause important economic losses during the postpartum period due to poor 81 
reproductive performance, lower milk production and an increase in the culling rate in comparison 82 
with non-affected cows. The animals affected by metritis are unable to control the growth of aerobic 83 
and anaerobic bacteria in uterine lumen due to an abnormal post-partum uterine involution that may 84 
be triggered by immune, nutritional and management factors [4]. Metritis is characterized by an 85 
inflammation of the uterine tract with local and/or systemic implications for the cow [5]. Therefore, 86 
diagnosis and treatment of postpartum uterine diseases is common in dairy practice.   87 
It is very important to clearly define the diagnostic criteria for metritis in cows. Thus, two types of 88 
metritis are usually observed under field conditions in the early postpartum period (1-21 days after 89 
parturition). On one hand, acute puerperal metritis (APM) is diagnosed in cows that have an 90 
abnormally enlarged uterus and a fetid, watery, reddish-brown uterine discharge, which is also 91 
associated with clinical signs of systemic disease (decreased milk yield, dullness or other signs of 92 
toxemia) and fever (>39.5ºC) within 21 days postpartum. On the other hand, clinical metritis (CM) 93 
is described in cows that have an abnormally enlarged uterus and a purulent uterine discharge 94 
detectable in the vagina within 21 days after parturition in the absence of clinical signs of systemic 95 
disease [6, 7, 8 ]. In any case, diagnosis of metritis is challenging for researchers and practitioners 96 
under field conditions [6, 7, 9 ] and the distinction between APM and CM is frequently not 97 
straightforward. Fortunately, the basis of the treatment is common for both types of metritis [10]. 98 
 It has been described in the literature that the treatment for cows suffering from metritis during the 99 
early post partum period is important to minimize this risk of low milk production, increase 100 
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reproduction performance in the next gestation and reduce culling risk [7]. There are many 101 
treatment protocols for cows with metritis. These treatments include various combinations of 102 
antimicrobials, administered by intrauterine and/or parenteral routes, and/or hormones [7, 8]. Thus, 103 
beta-lactamic antibiotics (mainly amoxicillin and cephalosporins) are efficacious to treat and 104 
prevent metritis after their parenteral administration under field conditions [10, 11]. Tetracyclines 105 
administered by intrauterine route are extensively used in uterine disease, although their efficacy 106 
has been questioned in the literature [12, 13, 14]. 107 
 108 
The objective of this study was to assess the impact of two different treatments for metritis during 109 
early postpartum period (1-21 days) in dairy cows by measuring their reproductive performance in 110 
the next gestation. The endpoints to measure the reproductive performance included: the conception 111 
rate at first AI, the number of days at conception and the proportion of non-pregnant cows at >150 112 
days in milk production (DIM).  113 
 114 
2.- Materials and Methods 115 
2.1- Animals and herd. 116 
During a five-year period (January 2009- January 2014), a total of 1222 cow parturitions were 117 
evaluated for routine post-partum examination; of these, 414 corresponded to heifers and 808 to 118 
multiparous cows. Parturitions complicated by other diseases that could also affect the reproductive 119 
performance (clinical ketosis, left displaced abomasum (LDA), clinical mastitis, lameness, 120 
pneumonia, ovarian disorders such as ovarian cysts and other uterine disease such as endometritis 121 
and pyometra) were excluded from the study. Culled or dead cows from either group without full 122 
reproductive history were also excluded. Eventually, 1044 parturitions were finally included in the 123 
study, 387 corresponding to heifers and 657 to multiparous cows. The exact numbers of excluded 124 
cows for the various reasons exposed, as well as group allocation for enrolled cows are detailed in 125 
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Figure 1.   126 
The study was conducted on a single high production commercial dairy farm in Lleida (North East 127 
Spain) over a period of five years (2009-2014). During the study period, this farm was housing an 128 
average of 330 lactating Holstein cows with an average production of 11,100 kg of milk (3.6% Fat 129 
and 3.3% Protein) in 305 days by cow. Cows were housed in five straw-bedded free- stall barns and 130 
they were fed a total mixed ration consisting of corn silage, grass silage, and concentrates. Cows 131 
were milked three times a day (at 4 AM, 12 PM, and 8 PM). Each cow was sampled and analyzed 132 
for milk quality (fat, protein, and lactose concentration) and somatic cell count by the Central 133 
Laboratory for Milk Recording (ALLIC, Catalonia) once a month. 134 
Breeding management was carried out by AI with Holstein semen and performed by a highly 135 
trained technician or veterinarians specialized in cattle reproduction. Cows were bred on observed 136 
estrus or diagnosed by a computerized pedometry system (Afimilk, Kibbutz Afikim, 1514800, 137 
Israel). Breeding programs based on the use of hormones were not applied and it was decided not to 138 
inseminate heifers and multiparious cows before 90 and 70 days post-partum, respectively. This 139 
decision was made considering historic data about reproductive performance in this particular farm.  140 
Transrectal ultrasonography (Easi Scan, 4.5 MHz - 8.5 MHz, BCF Technology, Ltd. Scotland) was 141 
used to perform pregnancy diagnosis at 32-40 days post AI as well as to detect uterine and/or 142 
ovarian disorders such as clinical endometritis, pyometra, ovarian cysts and ovarian cyclicity 143 
failure. This reproductive control was carried out every Tuesday and Friday and also included post -144 
partum examination (1-21 post-partum) and diagnosis and treatment of non-cycling or silent estrus 145 
cows. Non-cycling or silent estrus cows were treated with hormones. Various combinations of 146 
prostaglandins, gonadotropin-relising hormone GnRH and progesterone were used according to 147 
clinical criteria. In any case, these animals were excluded from the study to avoid any confounding 148 
factor in the data analysis. Finally, animals diagnosed and treated for other uterine and/or ovarian 149 
disorders outside the period of 1-21 days postpartum were excluded from the study to avoid any 150 
bias. 151 
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Clinical, reproduction, production and management data were recorded by the herd manager and the 152 
attending veterinarians using specific software (Afimilk, Kibbutz Afikim, 1514800, Israel). Lleida 153 
has a long “heat stress risk season” (from May to October,) that could affect the reproductive 154 
performance [15]. It is well known that heat stress can affect immunological status of the cows [16] 155 
and it could significantly affect the prevalence of uterine diseases and/or its severity. For the 156 
purposes of this study, the year was divided in four periods; 1 (1st January-31st March), 2 (1st 157 
April-30th June), 3 (1st July-30th September) and 4 (1st October-31st December).  158 
Other factors that have been described as affecting the reproductive performance of cows are the 159 
origin of semen (bull factor) and the technicians that perform the AI. Both factors were excluded 160 
from the data analysis because the same number of cows were inseminated in each experimental 161 
group regarding the origin of semen and the technician. 162 
 163 
2.2.- Definition of metritis case 164 
All the cows underwent a clinical examination every 24 hours during the first 21 days post-partum. 165 
For each animal, the ruminal motility, breathing rate, consistency of the faeces, rectal temperature, 166 
milk production, pedometry readings, body weight (BW) and milk conductivity were recorded. 167 
Additionally, rectal palpation and observation of vaginal discharge were carried out every Tuesday 168 
and Friday from day 1 to day 21 postpartum, (Table 1).  169 
Vaginal discharge (VD) was collected through rectal palpation massage to minimize not only 170 
contamination of the vagina and uterus but also microtrauma in the area. Quantity, color, proportion 171 
of pus, consistency and smell were evaluated [6]. All examinations were performed by the same 172 
veterinarian in order to minimize bias in the clinical record [17]. Cows that did not expel their fetal 173 
membranes (44 out of 1222) within 24 hours postpartum were diagnosed with retained fetal 174 
membranes (RFM). These animals were treated with one injection of 37.5 mg of sodium selenium 175 
and 1250 mg of α-Tocoferol acetate (Hipravit Selenio, HIPRA, Spain) and oral calcium (Bovicalk, 176 
Boehringer Ingelheim, Germany) every 12 hours until fetal membranes were expelled.  In these 177 
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cows, rectal palpation was performed every 24h. If fever (>39,5ºC) was present, animals were 178 
treated with flunixin meglumine (Finadyne®, MSD Animal Health) at a dose of 2.2 mg/Kg BW/ 24 179 
h for three days. Once fetal membranes were expelled (average of 48h postpartum), animals were 180 
classified according to Table 1. No attempt was made to manually remove the retained fetal 181 
membranes.  182 
  183 
In this study, metritis (APM and CM) was diagnosed in animals that had an abnormally enlarged 184 
uterus and a purulent or a fetid red-brown watery uterine discharge detectable in the vagina within 185 
21 days after parturition. The presence or absence of pyrexia (>39.5ºC) and other signs of systemic 186 
illness such as reduced milk yield, dullness, inappetence or anorexia, elevated heart rate, and 187 
apparent dehydration determined if animals were included in the APM group (present) or  the CM 188 
group (absent) [6]. Cows treated with anti-inflammatory drugs, antimicrobial drugs or hormones for 189 
diseases not related with the study (e.g., acute mastitis, lameness, LDA, ketosis, other uterine or 190 
ovary disorders) were excluded from the trial.  191 
 192 
2.3.- Experimental design 193 
Cows were included in the study at day 1 after calving. Reproductive performance of healthy cows 194 
was used as reference (control group). Cows suffering from metritis were randomly allocated to one 195 
of two groups according to the last digit of their ear tag. Thus, cows with an odd number (1, 3, 5, 7,  196 
9) were allocated to P group. In this group, cows only received parenteral amoxicillin by 197 
intramuscular route. Cows with an even number in their ear tag (0, 2, 4, 6, 8) were allocated to 198 
group P+I. In this group, cows received parenteral amoxicillin by intramuscular route plus an 199 
intrauterine infusion with oxytetracycline. Briefly, cows included in group P received a systemic 200 
antimicrobial treatment of amoxycillin trihidrate (Amoxoil Retard®, Laboratiorios SYVA SA) at 15 201 
mg/kg BW every 48h by intramuscular route for three times. Injection was applied on the neck and 202 
the injection volume was always less than 20 mL on the same inoculation point. Cows included in 203 
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the P+I group received the same systemic treatment as group P plus 8000 mg of oxytetracycline 204 
dihidrate (Tenalina L.A.®, CEVA Santé Animal) (200 mg/ml) via intrauterine infusion every 72-96 205 
hours twice.  Intrauterine infusion was applied with a disposable uterine catheter (53.5 cm Bovivet, 206 
Kruuse, Denmark) and a single use 50 cm
3
syringe. Cows that were diagnosed with metritis were 207 
considered cured when its classification was M0 or M1 (Table 1) after two regular rechecks. Cows 208 
allocated in any of the groups that showed fever were also treated with flunixin meglumine 209 
(Finadyne®, MSD Animal Health) at a dose of 2.2 mg/Kg BW/24 h for 3 days. 210 
 211 
2.4.- Monitoring of antimicrobial susceptibility throughout the trial 212 
Antimicrobial susceptibility (AS) for Escherichia coli (EC) and Trueperella pyogenes (TP) against 213 
amoxicillin and oxytetracycline was monitored every third month in this farm in, at least, four 214 
clinical cases. Briefly, AS tests were performed using the agar dilution method according to the 215 
Clinical Laboratory Standard Institute (CLSI) guideline M31-A3 in a commercial diagnostic 216 
laboratory. The threshold values to distinguish between susceptible and resistant microorganisms 217 
are detailed in Table 2. 218 
 219 
2.5.- Statistical Analysis. 220 
All statistical analyses were carried out using the SAS system V.9.1.3 (SAS institute Inc, Cary, NC, 221 
USA). For all analyses, the individual cow was used as the experimental unit and the data was 222 
grouped taking into account the parity of the cows: Heifers (first parturition) versus multiparous 223 
cows (two to six parturitions). The significance level (p) was set at 0.05 with statistical tendencies 224 
reported when P<0.10. The variables included in the statistical analyses were classified as nominal 225 
(pregnancy and delivery season), ordinal (parity) or continuous (days to conception and DIM). 226 
Shapiro Wilk´s and Levene tests were used to evaluate the normality of the distribution of the 227 
continuous variables and the homogeneity of variances, respectively. Statistical analyses were 228 
performed to test the association between the different experimental groups (control, P or P+I) with 229 
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the conception rate at first AI, days to conception and the proportion of non-pregnant cows with a 230 
DIM higher than 150 days. Contingency tables (Chi-square or Fischer exact tests) were used when 231 
the association between nominal and ordinal variables was assessed. To study the association 232 
between nominal or ordinal variables with the continuous non-normally distributed variables, the 233 
Wilcoxon test (with the U Mann-Whitney test to compare each pair of values) was used. To analyse 234 
the association between continuous normally distributed variables and nominal or ordinal variables, 235 
an ANOVA test (with Student’s T-test to compare each pair of values) was used. 236 
 237 
3.- Results. 238 
3.1.- Description of metritis in the population 239 
Metritis was diagnosed in 288 out of 1044 parturitions finally included in the study, (27.5% 240 
prevalence). In particular, metritis was diagnosed in 30.5% (118 out of 387) and 25.9% (170 out of 241 
657) of parturitions resulting from heifers and multiparous cows, respectively. Cows scored as M2 242 
(Table 1) were diagnosed with APM in 83 out of 288 cases of metritis (28.8% prevalence). These 243 
animals had an abnormally enlarged uterus, a purulent or a fetid red-brown watery uterine discharge 244 
detectable in the vagina, pyrexia (>39.5ºC) and/or systemic illness such as reduced milk yield, 245 
dullness, inappetence or anorexia, elevated heart rate, and apparent dehydration. Two-hundred and 246 
five out of 288 cows with uterine disease (71.2% prevalence) were diagnosed with CM (cows 247 
graded as M2 but without pyrexia (<39.5ºC) and/or systemic illness). Taking parity into account, 248 
32.2% of heifers affected with metritis, suffered from APM (38 out of 118) and 67.8% from CM (80 249 
out of 118). Within multiparous cows, 30.6% (52 out of 170) and 69.4% (118 out of 170) were 250 
diagnosed as APM and CM, respectively. Significant differences in the prevalence of each type of 251 
metritis between heifers and multiparous cows or within groups of treatment were not observed  at 252 
the beginning of the trial (basal homogeneity). Thus, 27.9% (43 out of 154) and 72.2% (111 out of 253 
154) of the animals were diagnosed as APM and CM, respectively in Group P and the prevalence of 254 
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APM was 29.8% (40 out of 134) and 70.2% of CM (94 out of 134), respectively for group P+I at 255 
the beginning of the trial. 256 
 257 
3.2.- Reproductive performance in the population 258 
Reproductive performance was not significantly affected  by the number of parity, the season at first 259 
AI, the season at conception, the bull or the inseminator that carried out the AI, neither in healthy 260 
nor in metritis affected cows. Considering all the animals included in the study (healthy and metritis 261 
affected cows), the number of days at first insemination was not significantly different between 262 
heifers and multiparous cows but the number of days at conception was significantly higher in 263 
multiparous cows (129.5+60.3) than in heifers (118.6+53). In heifers, the conception rate at first 264 
insemination was significantly higher than in multiparous cows, whereas the percentage of non-265 
pregnant animals at >150 DIM was significantly lower than in multiparous cows. For this reason, 266 
the analysis of the treatment efficacy was carried out separately for heifers and multiparous cows.  267 
 268 
3.3.- Bacteriological examination 269 
The isolates of EC and TP obtained were susceptible against amoxicillin and/or oxytetracycline 270 
throughout the trial, considering the threshold values detailed in Table 2.  271 
 272 
3.4.- Effect of the two antibiotic treatments on the reproductive performance 273 
In heifers with metritis, The P+I treatment was able to significantly reduce the number of days at 274 
first insemination (80.5±11.6 vs 91.9±24.2) and at conception (116.8±50.5 vs 151.5±67.7) in 275 
comparison with the P treatment. In the case of multiparous cows, this significant effect was only 276 
observed in the case of days at conception (140.8±62.7 vs 166.8±67.5) (Figure 2). In heifers, when 277 
the P+I group was compared to the control group, no significant differences were observed for any 278 
of these two parameters. However, in the case of multiparous cows, the number of days at 279 
conception for both P and P+I groups was significantly higher than in the control group 280 
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(120.6±55.5) (Figure 2). The P+I treatment was able to significantly increase the percentage of 281 
pregnant cows at first insemination for both heifers (47.5%) and multiparous cows (30.5%) in 282 
comparison with the P treatment (28.2% for heifers and 15.3% for multiparous) (Figure 3). The P+I 283 
treatment was able to significantly decrease the percentage of non-pregnant cows at >150 DIM 284 
when compared to the P treatment (18.3 % vs 42.4% for heifers and 38% vs 57.1% for multiparous 285 
cows, respectively). Finally, in heifers, no significant differences in the percentage of pregnant 286 
animals at first insemination or in the percentage of non-pregnant cows at >150 DIM were observed 287 
between the control group and the P+I group. However, in multiparous cows, both parameters for 288 
the P and P+I groups had significantly higher values than those observed in the control group 289 
(Figure 3). 290 
 291 
4.- Discussion. 292 
The main goal of this study was to assess the impact of two different treatments, parenteral only vs 293 
parenteral plus intrauterine infusion, for dairy cows affected with metritis by measuring their 294 
reproductive performance in the next gestation: days at first AI, conception rate at first AI and 295 
percentage of non pregnant animals at 150 DIM. These results were compared with the values 296 
observed for healthy cows as a reference. The authors did not consider the possibility to include a 297 
negative control group (affected with metritis  and not treated with antimicrobials) due to welfare 298 
reasons and the increased risk of death or culling for these non-treated sick animals. Metritis 299 
decreases the reproductive performance of dairy cattle [3]. In this study, the control group (healthy 300 
cows) always showed better reproductive performance than metritis-affected cows. The results 301 
suggest that the combination of amoxicillin, administered by parenteral route, plus intrauterine 302 
infusion of oxytetracycline is more efficacious than the administration of parenteral amoxycillin 303 
alone for the treatment of metritis, when taking into account the reproductive performance in the 304 
next gestation as an end-point. This statement was true for both heifers and multiparous cows, 305 
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although the positive results were more consistently observed in heifers than in multiparous cows 306 
for all the parameters evaluated. 307 
In the literature, various techniques to diagnose metritis in cows can be found [6, 9]. In this study, 308 
metritis (APM and CM) was described as an abnormally enlarged uterus and a fetid watery red-309 
brown or purulent uterine discharge showing or not pyrexia (>39.5ºC), with or without signs of 310 
systemic illness within 21 days after parturition [6]. The authors decided to include both pyretic and 311 
non pyretic animals since this is the way it has been previously described by other authors [4, 10]. 312 
The authors used a method with high sensitivity to diagnose metritis in cows, which avoids the risk 313 
of underestimating metritis if only milk production or rectal temperature are considered as 314 
diagnostic, but at the same time, trying to make it a reasonably fast, sensitive and economic 315 
procedure for the farmer. The procedure takes some time to implement but once established as a 316 
routine in the farm, the authors believe that it can be very useful to diagnose post-partum disease 317 
and treat the animals during an early stage of illness, which improves the productive and 318 
reproductive performance of the cows. It means that the animals included in this study were 319 
diagnosed in a very early stage of the disease. This fact must be taken into account when the 320 
treatment efficacy is compared with the results obtained by other authors. 321 
 322 
In this study, the overall prevalence of metritis is close to 28%. This prevalence can vary 323 
considerably between heifers and cows, between different farms and between studies. Thus, values 324 
between 2.2% and 42.3% have been observed in previous studies [14, 18, 19]. For this reason, the 325 
farm included in this trial could be considered representative of a high production dairy cattle 326 
operation with a prevalence of metritis within reported values. Thus, the reproductive performance 327 
of healty or metritis-affected cows was not affected by factors directly or indirectly associated with 328 
management (season at first AI, season at conception, the bull and the inseminator that carried out 329 
the AI). Taken together, these results suggest that the farm where the study was carried out was 330 
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appropriate to assess the impact of two different treatments for metritis in dairy cows by measuring 331 
their reproductive performance in the next pregnancy. 332 
 333 
The bacteria most commonly isolated from metritis-affected dairy cows are well described in 334 
several studies; these include EC and TP [20, 21, 22]. Fusobacterium necrophorum and 335 
Bacterioides spp are also recognized as opportunistic bacteria that can cause metritis [23, 24]. In 336 
particular, it has been long suggested that uterine infections might depend on pathogenic synergism 337 
between EC, TP and bacteria from other groups.  However, recent studies have suggested that the 338 
diversity of the uterine bacterial composition in dairy cows is likely to be even more complex than 339 
previously described by traditional culture-dependent methods [25]. Additionally, it is necessary to 340 
know the AS of the bacteria involved in clinical cases of bovine metritis in order to choose the most 341 
suitable antimicrobial. However, it is only feasible to determine this antimicrobial susceptibility in 342 
the isolated bacteria. In our case, the isolates of EC and TP obtained were susceptible against 343 
amoxicillin and/or oxytetracycline throughout the trial. Thus, the use of both antimicrobials in this 344 
farm did not seem to generate antimicrobial resistance for these bacteria during five years. 345 
Nevertheless, the diversity of the bacterial species involved in clinical cases of metritis makes 346 
absolutely compulsory to carry out clinical trials that measure clinical efficacy instead of carrying 347 
out only pharmacokinetic/pharmacodynamic studies that only take into account pharmacodynamic 348 
data from only the most commonly isolated bacteria (EC and TP) [26]. 349 
 350 
The use of antimicrobials is widely accepted to cope with infections in the genital tract, mainly in 351 
the case of metritis [27]. The rationale behind this therapeutic approach is to reduce the number of 352 
pathogens in the uterine cavity and consequently mitigate the associated inflammation, enhance the 353 
local immune defense, and facilitate the repair of the endometrium for a faster return to a normal 354 
uterine status. Unfortunately, there are few available data about the penetration of parenterally-355 
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administered antibiotics into the cow genital tract. In humans, an endometrium to plasma 356 
concentration ratio of 0.6 and 0.4 for quinolones and a beta-lactamics, respectively, has been 357 
established [28, 29]. It is possible that a similar ratio could be achieved in cows. Intrauterine 358 
administration of antibiotics is expected to reach a higher antibiotic concentration in the 359 
endometrium compared to systemic administration and it is a common route to administer 360 
antimicrobials for metritis in cows and mares [30]. Thus, considering the administered dose of 361 
oxytetracycline (8000 mg) and the uterine volume post-partum (2000 mL) [31], an extraordinarily 362 
high oxytetracycline concentration in uterine lumen (4 mg/mL) was expected to be achieved. This 363 
concentration is notably higher than the established Minimum inhibitory Concentration for the 90% 364 
of the strains (MIC9) for AP and EC in case of bovine metritis [32, 33, 34]. 365 
 366 
To the best of the authors’ knowledge, no previous studies have explored the same combination of 367 
antimicrobials to treat cows diagnosed with early postpartum metritis.  However, it has been 368 
described in the literature that the administration of beta-lactamics by parenteral route is able to 369 
improve the reproductive performance of metritis-affected cows [35]. The use of ceftiofur, 370 
administered intramuscularly, with or without a combination of cloxacillin plus ampicillin by 371 
intrauterine infusion, did not show differences in reproductive performance between groups in cows 372 
diagnosed with toxic puerperal metritis (TPM) [36]. In conclusion, there is a lot of variation in the 373 
treatment outcome of uterine disease using beta-lactamic antibiotics [13, 37, 38, 39, 40]. Similar 374 
studies have described a significant improvement in reproduction parameters applying an 375 
intrauterine infusion of tetracyclines in cows and heifers with CM [14] but other studies did not find 376 
significant differences in the treatment outcome between various combinations of intrauterine 377 
infusion of tetracyclines for the treatment of metritis [39], endometritis [12, 13] or retained fetal 378 
membranes [14, 42]. In our study, the combination of amoxicillin, by parenteral route, plus 379 
intrauterine infusion of oxytetracycline is more efficacious than using only the parenteral route. It 380 
must be highlighted that, in the current study, the dose of oxytetracyclines was higher and the 381 
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duration of administration was longer than the dosage regimen used in other studies [14, 39]. 382 
Globally, these results suggest that local treatment with antibiotics can be important to heal the 383 
genital tract and prepare it for the following pregnancy. The efficacy of intrauterine tetracycline 384 
might be related to other uncultured or unknown organisms that are sensitive to this antimicrobial 385 
and that are not easily isolated with standard microbiological techniques. Finally, this efficacy 386 
might also be related to non-antimicrobial effects of tetracyclines such as anti-inflammatory effects. 387 
In this regard, tetracyclines are potent inhibitors matrix metalloproteinases  and inducible Nitric 388 
Oxide Synthase, which are known to play a role in the mediation and control of mucosal 389 
inflammation and immune response [43, 44]. 390 
 391 
In conclusion, based on reproductive performance as an end-point parameter, treatment of metritis 392 
with parenteral amoxicillin plus oxytetracycline via intrauterine route was superior in comparison 393 
with only the parenteral administration of amoxicillin.  394 
 395 
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 511 
Table 1. Classification of cows according to the type of vaginal discharge during the post-partum 512 
period  513 
  514 
CODE TYPE OF VAGINAL 
DISCHARGE 
DIAGNOSIS TREATMENT 
M0 No vaginal discharge.  Healthy None 
M1 Normal lochial 
secretion, odorless, 
viscous and translucid.  
Healthy None 
M1S Normal lochial 
secretion, odorless, 
viscous and reddish 
brown.  
Healthy None 
M2 Purulent or fetid, 
watery  and reddish-
brown  
Metritis P: Parenteral Amoxycillin 
P+I: Parenteral 
Amoxicillin plus 
intrauterine infusion of 
Oxytetracycline. 
 515 
516 
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Table 2.- Minimal inhibitory concentration (MIC) breakpoints for Escherichia coli and Trueperella 517 
pyogenes isolated from bovine metritis cases 518 
 519 
   MIC 
breakpoint 
( g/mL) 
   
  Escherichia 
coli 
  Trueperella 
pyogenes 
 
 S I R S I R 
Antimicrobial 
agent 
      
Amoxicillin* <0.25 0.5 >1 <2 4 >8 
Oxytetracycline** <4 8 >16 <4 8 >16 
* According to the breakpoint established for similar pathogens in other veterinary species 520 
** Derived from human data 521 
S= Sensitive, I= Intermediate, R= Resistant 522 
 523 
 524 
 525 
 526 
 527 
 528 
 529 
 530 
 531 
 532 
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 533 
Figure 1.- Allocation of parturitions from animals discarded and enrolled in the study . 534 
 535 
 536 
 537 
 538 
539 
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Figure 2.- Number of days at first artificial insemination (A) and at conception (B) in healthy cows 540 
(control) or in metritis affected animals treated with two different treaments (P or P+I). Groups 541 
connected with different letter or number means statistically significant differences between them 542 
(p<0.05). 543 
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Figure 3.- Conception rate at first insemination (A) and percentage of non-pregnant cows at >150 559 
days DIM (B) in healthy cows (control) or in metritis affected animals treated with two different 560 
treaments (P or P+I). Groups connected with different letter or number means statistically 561 
significant differences between them (p<0.05). 562 
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Highlights 
 
The objective of this study was to assess the impact of two different treatments for metritis on 
dairy cows by measuring its reproductive performance in the next gestation.  
Cows suffering metritis were randomly assigned to two groups: 1) P+I group: Animals receiving 
parenteral amoxicillin by intramuscular route plus intrauterine lavage with oxytetracicline; 2) P 
group: Animals receiving only parenteral amoxicillin by intramuscular route. Furthermore, 
reproductive performance of non-suffering metritis cows (healthy ones) were used as 
reference values (control group). 
The endpoints to measure its reproductive performance were the conception rate at first 
artificial insemination (AI), the number of days at conception and the proportion of non-
pregnant cows at more than 150 days of beginning milk production (>150 days DIM).  
The P+I treatment was able to reduce significantly (p<0.05) the number of days at first 
insemination and at conception in comparison with the P treatment in heifers. In the case of 
multiparous cows, this significant effect was only observed in the case of days at conception.  
The P+I treatment was able to increase and decrease significantly (p<0.05) the percentage of 
pregnant animals at first insemination and the percentage of non-pregnant cows at >150 days 
DIM, respectively for heifers and multiparous cows in comparison with the P treatment. 
 
*Highlights (for review)
